Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients.
Anemia is one of the most common problems in chronic kidney disease (CKD). In several cases, despite comprehensive investigations, definite causes of anemia frequently remain unknown. We aimed to analyze the factors that possibly affect anemia in CKD patients who were referred for hematology consult...
Main Authors: | Kamalas Amnuay, Nattachai Srisawat, Kitsada Wudhikarn, Dr, Thamathorn Assanasen, Chantana Polprasert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/8183 |
Similar Items
-
Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients
by: Yu-Ting Lee, et al.
Published: (2022-09-01) -
Relationships between blood bone metabolic biomarkers and anemia in patients with chronic kidney disease
by: Fan Li, et al.
Published: (2023-12-01) -
“Ideal” parathyroid hormone in erythropoietin‐stimulating agents‐resistant anemia
by: Bilal Ashraf, et al.
Published: (2022-02-01) -
Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients
by: Jie Song, et al.
Published: (2023-10-01) -
<sup>18</sup>F-Fluorocholine PET/CT Compared with Current Imaging Procedures for Preoperative Localization of Hyperfunctioning Parathyroids in Patients with Chronic Kidney Disease
by: Samuel Aymard, et al.
Published: (2023-04-01)